1. Home
  2. ABUS vs PDS Comparison

ABUS vs PDS Comparison

Compare ABUS & PDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABUS
  • PDS
  • Stock Information
  • Founded
  • ABUS 2005
  • PDS 1951
  • Country
  • ABUS United States
  • PDS Canada
  • Employees
  • ABUS N/A
  • PDS N/A
  • Industry
  • ABUS Biotechnology: Pharmaceutical Preparations
  • PDS
  • Sector
  • ABUS Health Care
  • PDS
  • Exchange
  • ABUS Nasdaq
  • PDS Nasdaq
  • Market Cap
  • ABUS 672.1M
  • PDS 581.6M
  • IPO Year
  • ABUS N/A
  • PDS N/A
  • Fundamental
  • Price
  • ABUS $3.08
  • PDS $43.35
  • Analyst Decision
  • ABUS Strong Buy
  • PDS Buy
  • Analyst Count
  • ABUS 4
  • PDS 1
  • Target Price
  • ABUS $5.50
  • PDS $95.00
  • AVG Volume (30 Days)
  • ABUS 827.5K
  • PDS 107.3K
  • Earning Date
  • ABUS 05-14-2025
  • PDS 04-23-2025
  • Dividend Yield
  • ABUS N/A
  • PDS N/A
  • EPS Growth
  • ABUS N/A
  • PDS N/A
  • EPS
  • ABUS N/A
  • PDS 5.20
  • Revenue
  • ABUS $6,403,000.00
  • PDS $1,301,611,298.00
  • Revenue This Year
  • ABUS $14.57
  • PDS $1.35
  • Revenue Next Year
  • ABUS $15.84
  • PDS $0.99
  • P/E Ratio
  • ABUS N/A
  • PDS $7.77
  • Revenue Growth
  • ABUS N/A
  • PDS N/A
  • 52 Week Low
  • ABUS $2.63
  • PDS $36.20
  • 52 Week High
  • ABUS $4.72
  • PDS $79.07
  • Technical
  • Relative Strength Index (RSI)
  • ABUS 39.99
  • PDS 50.15
  • Support Level
  • ABUS $2.94
  • PDS $39.67
  • Resistance Level
  • ABUS $3.42
  • PDS $45.85
  • Average True Range (ATR)
  • ABUS 0.18
  • PDS 1.29
  • MACD
  • ABUS -0.04
  • PDS 0.39
  • Stochastic Oscillator
  • ABUS 17.72
  • PDS 59.55

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

Share on Social Networks: